AU2002333840A1 - Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation - Google Patents

Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation

Info

Publication number
AU2002333840A1
AU2002333840A1 AU2002333840A AU2002333840A AU2002333840A1 AU 2002333840 A1 AU2002333840 A1 AU 2002333840A1 AU 2002333840 A AU2002333840 A AU 2002333840A AU 2002333840 A AU2002333840 A AU 2002333840A AU 2002333840 A1 AU2002333840 A1 AU 2002333840A1
Authority
AU
Australia
Prior art keywords
xenogenic
allogenic
antigens
identification
mediated precipitation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002333840A
Inventor
Reinhard Zeidler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/EP2002/010318 external-priority patent/WO2003025568A2/en
Publication of AU2002333840A1 publication Critical patent/AU2002333840A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AU2002333840A 2001-09-14 2002-09-13 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation Abandoned AU2002333840A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10145384.1 2001-09-14
DE10145384 2001-09-14
DE10151051A DE10151051B4 (en) 2001-09-14 2001-10-16 Identification of antigens by xenogeneic, allogenic or autologous antibody-mediated precipitation
DE10151051.9 2001-10-16
PCT/EP2002/010318 WO2003025568A2 (en) 2001-09-14 2002-09-13 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation

Publications (1)

Publication Number Publication Date
AU2002333840A1 true AU2002333840A1 (en) 2003-04-01

Family

ID=7699064

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002333840A Abandoned AU2002333840A1 (en) 2001-09-14 2002-09-13 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation

Country Status (2)

Country Link
AU (1) AU2002333840A1 (en)
DE (1) DE10151051B4 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713352A (en) * 1981-08-31 1987-12-15 Sloan-Kettering Institute For Cancer Reseach Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
DK0991945T4 (en) * 1997-06-26 2008-06-09 Univ Michigan Method for identifying tumor antigens with serum autoantibodies

Also Published As

Publication number Publication date
DE10151051A1 (en) 2003-04-10
DE10151051B4 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
AU2002256895A1 (en) Anti-TRAIL-R antibodies
MXPA03001229A (en) Anti-il-12 antibodies, compositions, methods and uses.
MXPA03007319A (en) Modified anti-egfr antibodies with reduced immunogenicity.
WO2003045840A3 (en) Mesoporous materials and methods
IL161968A0 (en) Anti-il-6 antibodies, compositions, methods and uses
AU2002235312A1 (en) Certain silicone polyethers, methods for making them and uses
AU2002314825A1 (en) Anti-p40 immunoglobulin derived proteins, compositions, methods and uses
MXPA03006117A (en) Flange bearing.
AU2002359495A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
AU2002349543A1 (en) Tumor antigens
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
AU2001254937A1 (en) (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-( 3r,5s)-dihydroxyhept-6-enoic acid.
AU2002306748A1 (en) Anti-gpe antibodies, their uses, and analytical methods for gpe
AU2002365269A1 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2002251821A1 (en) Nicotine immunogens and antibodies and uses thereof
AU2002333840A1 (en) Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation
AU2002365925A1 (en) Rsv proteins, antibodies, compositions, methods and uses
AU2002316619A8 (en) Antimicrobial nucleic acid antibodies, and materials and methods for making and using same
AU2002221261A1 (en) Method, antigen and antibody for distinguishing viable and apoptotic cells
AU2002307943A1 (en) M. catarrhalis antigens
AU2002326177A1 (en) Cage antigen
AU2002231806A1 (en) H. influenzae antigen basb213
AU2001100188A4 (en) Perfumed credit card
AU4431600A (en) Novel pollen antigen

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase